www.fdanews.com/articles/85510-novavax-executes-agreement-for-38-million-secondary-public-offering
NOVAVAX EXECUTES AGREEMENT FOR $38 MILLION SECONDARY PUBLIC OFFERING
March 23, 2006
Novavax Inc. announced that it
has entered into a definitive agreement for a $38 million registered direct offering
of 5,205,479 shares of its common stock at a price of $7.30 per share. The shares
of common stock will be issued pursuant to an effective shelf registration statement.
Small
Times